Skip to main content

Desmoid Tumors Market Growth Statistics, Key Players, Industry Size and Trends

MRFR Estimated That “Desmoid Tumors Market Is Expected to Grow at a CAGR 4.5% During the Forecast Period Of 2017-2023”.

Desmoid Tumors Market Overview

Desmoid tumors are the benign fibrous growths which usually develops in the fibrous tissue of the body, commonly in the arms, legs or midsection, and sometimes in the head and neck. According to the U.S National Library of Medicine, Desmoid tumors are very rare as the rate of occurrence is estimated to be 1 to 2 per 500,000 people worldwide. It is also stated that nearly 900 to 1,500 new cases are registered per year in the United States.

Tumors associated with familial adenomatous polyposis (FAP) are less common than sporadic desmoid tumors. On the molecular level, desmoid tumor is characterized by one of the two mutations in the gene i.e. mutations in the adenomatous polyposis coli (APC) gene, or in the β-catenin gene, CTNNB1. During diagnostic procedures CTNNB1 mutation is detected, especially, when pathological differential diagnosis is difficult.


The symptoms of desmoid tumors include a painless swelling or lump, pain and obstruction of the bowels, limping, pain caused by compressed nerves or muscles, and others. For the diagnosis of desmoid tumor there are many non-invasive methods available to detect desmoid tumor which include ultrasound, MRI scan, and CT scan. The actual diagnosis of this tumor can be made only after examining a small piece of the tumor by a trained pathologist.

High cost of treatment & management of desmoid tumors and related disorders, and lack of infrastructure in middle- and low-income countries may hamper the growth of the market.

Competitive Analysis:

Some of key the players in the Desmoid Tumors Market are
  • Amgen Inc.
  • Novartis AG
  • Abbott Laboratories
  • Bayer AG
  • AbbVie Inc.
  • Beckman Coulter Inc.
  • Stryker Corporation
  • Debiopharm Group
  • Hoffmann-La Roche Ltd
  • and others.

Desmoid Tumors Market Segmental Analysis:

The desmoid tumors market is segmented on the basis of diagnosis, treatment, and end-user.

On the basis of diagnosis, market is segmented into biopsy, electron microscopic examination, immunohistochemical analysis, others

On the basis of treatment, market is classified into surgery, radiation therapy, anti-inflammatory medication, hormone therapy, chemotherapy, novel molecular-targeted therapy, others. Novel molecular-targeted therapy is further segmented into gleevec based therapy, and sorafenib based therapy

On the basis of end-user, market is segmented into hospital, clinics, and others.

Brows Complete Detailed Premium Research Report at https://www.marketresearchfuture.com/reports/desmoid-tumors-market-4859

Desmoid Tumors Market Regional Analysis:

The Americas dominate the desmoid tumors market owing to the rising awareness among people, and increasing healthcare expenditure. As per the facts suggested by the Centers for Disease Control and Prevention (CDC), it is found that out of total annual healthcare expenditure, 86% is for people with chronic health conditions in the United States. Furthermore, increasing participation of bigger players and new marketers towards advancement in treatment approaches have also attracted a great deal of attention.

Europe holds the second position in the desmoid tumors market. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in Europe region.

Asia Pacific is the fastest growing desmoid tumors market owing to the huge patient pool and developing healthcare technology.

The Middle East & Africa has the lowest market for desmoid tumors market due to lack of technical knowledge and poor medical facilities. 

LIST OF TABLES
Table 1 Desmoid Tumor Industry Synopsis, 2017 – 2023
Table 2 Desmoid Tumor Market Estimates And Forecast, 2017 – 2023, (USD Million)
Table 3 Desmoid Tumor Market By Region, 2017 – 2023, (USD Million)
Table 4 Desmoid Tumor Market By Diagnosis, 2017 – 2023, (USD Million)
Table 5 Desmoid Tumor Market By Treatment, 2017 – 2023, (USD Million)
Table 6 Desmoid Tumor Market By End Users, 2017 – 2023, (USD Million)
Table 7 North America Desmoid Tumor Market By Diagnosis, 2017 – 2023, (USD Million)
…To be Continued.


Contact Market Research Future:

Comments

Post a Comment

Popular posts from this blog

Dupuytren's contracture Market Size, Growth Analysis By Types, Treatment on Top Key Players

Dupuytren's contracture is a condition in which there is difficulty in articulating fingers due to formation of tissue knots under the skin. In severe conditions, the fingers become permanently bent in a flexed position. Dupuytren's contracture is typically not painful and generally affects the ring finger followed by the little and middle finger. The exact causes of Dupuytren's contracture are unknown however the risk factors include alcoholism, smoking, thyroid problems, liver disease, diabetes, previous hand trauma, epilepsy, family history etc. The market drivers for Dupuytren’s contracture market are, increase in risk factors rising incomes, growing screening, increasing geriatric population etc. The market restraints are cost of Dupuytren’s contracture surgery, complications and risk of the surgery, invasive nature of treatment, and regression of the disease even after treatment etc. The  global Dupuytren’s contracture market is expected to reach USD 5.5 billion ...
Post a Comment
Read more

Acoustic Insulation Market Size, Share, Trends, Application Analysis, Growth And Forecast 2021-2026

  The Global Acoustic Insulation Market share is expected to grow at more than 4.6% CAGR from 2019 to 2028. It is expected to reach above USD 19.6 billion by 2028. Acoustic Solutions as we know is an important ingredient for industrial and residential production. The Acoustic Insulation market for Acoustic Solutions has also seen a significant growth and is expected to see growing in coming years. There are few market drivers and restraints behind this growth. Technological changes in the automobile industry are leading complete makeover of industry. This make over will be gradual in its course. Development of Lithium-Ion battery, increasing preference of the consumer as well as nudging by government for the consumption of clean energy is leading to significant overhaul of the industry. Various regional markets have committed to reduce and ultimately stop the consumption of fossil fuel in coming decades. To tackle the issue of pollution and safety, India which is the fourth largest...
Post a Comment
Read more

Medical Billing Outsourcing Market Technological Scope, Future Trends and Growth Analysis by Types

Medical Billing Outsourcing Market Research Report: Information by Component (In House & Outsourced), Service (Front End Service, Middle End Service, & Back End Service), End User (Hospitals, Physician’s Office, & Others) — Global Forecast till 2023 The report presents a detailed analysis of  Medical Billing Outsourcing Market  by providing readers with a comprehensive overview of the market’s historical trajectory. The leading drivers and restraints affecting the global prostate cancer market are assessed in detail in the report. The historical impact of these drivers and restraints is analyzed in context of the current impact of these factors and projections are made for the likely impact of these drivers and restraints over the forecast period. Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. R1...
Post a Comment
Read more